BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8314261)

  • 1. Immunohistochemical phenotype of ovarian granulosa cell tumors: absence of epithelial membrane antigen has diagnostic value.
    Costa MJ; DeRose PB; Roth LM; Brescia RJ; Zaloudek CJ; Cohen C
    Hum Pathol; 1994 Jan; 25(1):60-6. PubMed ID: 8314261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
    Costa MJ; Walls J; Ames P; Roth LM
    Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
    Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
    Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibin and epithelial membrane antigen immunohistochemistry assist in the diagnosis of sex cord-stromal tumors and provide clues to the histogenesis of hypercalcemic small cell carcinomas.
    Riopel MA; Perlman EJ; Seidman JD; Kurman RJ; Sherman ME
    Int J Gynecol Pathol; 1998 Jan; 17(1):46-53. PubMed ID: 9475192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas.
    Costa MJ; Morris RJ; Wilson R; Judd R
    Hum Pathol; 1992 Jul; 23(7):787-97. PubMed ID: 1612579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate filamentous proteins in adult granulosa cell tumors. An immunohistochemical study of 25 cases.
    Otis CN; Powell JL; Barbuto D; Carcangiu ML
    Am J Surg Pathol; 1992 Oct; 16(10):962-8. PubMed ID: 1384370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian granulosa cell tumors with bizarre nuclei: an immunohistochemical analysis with fluorescence in situ hybridization documenting trisomy 12 in the bizarre component [corrected].
    Gaffey MJ; Frierson HF; Iezzoni JC; Mills SE; Clement PB; Gersell DJ; Shashi V; von Kap-Herr C; Young RH
    Mod Pathol; 1996 Mar; 9(3):308-15. PubMed ID: 8685233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid cell (steroid cell) tumor of the ovary: immunophenotype with analysis of potential pitfall due to endogenous biotin-like activity.
    Seidman JD; Abbondanzo SL; Bratthauer GL
    Int J Gynecol Pathol; 1995 Oct; 14(4):331-8. PubMed ID: 8598336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study.
    Aguirre P; Thor AD; Scully RE
    Int J Gynecol Pathol; 1989; 8(4):364-73. PubMed ID: 2478493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic and immunohistochemical evidence for considering ovarian myxoma as a variant of the thecoma-fibroma group of ovarian stromal tumors.
    Costa MJ; Morris R; DeRose PB; Cohen C
    Arch Pathol Lab Med; 1993 Aug; 117(8):802-8. PubMed ID: 7688213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool.
    Costa MJ; Ames PF; Walls J; Roth LM
    Hum Pathol; 1997 Nov; 28(11):1247-54. PubMed ID: 9385929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors.
    Anttonen M; Unkila-Kallio L; Leminen A; Butzow R; Heikinheimo M
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6529-35. PubMed ID: 16159935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian small cell carcinoma. Histogenetic considerations based on immunohistochemical and other findings.
    Aguirre P; Thor AD; Scully RE
    Am J Clin Pathol; 1989 Aug; 92(2):140-9. PubMed ID: 2474244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
    Chen L; Yang B
    Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic value of immunohistochemistry in ovarian sex cord-stromal tumors].
    Farah-Klibi F; Ben Slama S; Ben Hamouda S; Sfar R; Koubâa A; Ben Jilani S; Zermani R
    Tunis Med; 2008 Sep; 86(9):821-6. PubMed ID: 19472783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative immunohistochemical analysis of granulosa and sertoli components in ovarian sex cord-stromal tumors with mixed differentiation: potential implications for derivation of sertoli differentiation in ovarian tumors.
    Vang R; Herrmann ME; Tavassoli FA
    Int J Gynecol Pathol; 2004 Apr; 23(2):151-61. PubMed ID: 15084844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and Morphological Features of Bovine Granulosa Cell Tumours in Relation to Growth Pattern and Folliculogenesis.
    Teh APP; Kitahara G; Izzati UZ; Mori K; Fuke N; Hirai T; Yamaguchi R
    J Comp Pathol; 2021 Aug; 187():40-51. PubMed ID: 34503653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular differentiation in ovarian sex-cord-stromal and germ-cell tumors studied with antibodies to intermediate-filament proteins.
    Miettinen M; Wahlstrom T; Virtanen I; Talerman A; Astengo-Osuna C
    Am J Surg Pathol; 1985 Sep; 9(9):640-51. PubMed ID: 2996374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity of ovarian juvenile granulosa cell tumours with epithelial membrane antigen.
    McCluggage WG
    Histopathology; 2005 Feb; 46(2):235-6. PubMed ID: 15693901
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ovarian tumors with endocrine function].
    Guo LN; Liu TH; Sun AJ; Zhou Q
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.